Pathological gambling in patients with Parkinson's disease is associated with fronto-striatal disconnection: A path modeling analysis

Movement Disorders

Volumn 26, Issue 2, 2011, Pages 225-233

  Cilia, Roberto ^a,b,c   Cho, Sang Soo ^a,b   van Eimeren, Thilo ^a,b   Marotta, Giorgio ^d   Siri, Chiara ^c   Ko, Ji Hyun ^a,b   Pellecchia, Giovanna ^a,b   Pezzoli, Gianni ^c   Antonini, Angelo ^c,e   Strafella, Antonio P ^a,b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PARKINSON INSTITUTE   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^e UNIVERSITY OF PADOVA   (Italy)

Author keywords

Effective connectivity; Parkinson's disease; Pathological gambling; SPECT; SPM

Indexed keywords

DOPAMINE; LEVODOPA;

AGED; ANTERIOR CINGULATE; ARTICLE; BEHAVIOR; BRAIN PERFUSION; BRAIN REGION; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; CORPUS STRIATUM; COVARIANCE; DECISION MAKING; DISEASE SEVERITY; DOPAMINERGIC TRANSMISSION; FEMALE; FRONTO STRIATAL DISCONNECTION; HUMAN; INSULA; MALE; NERVE CELL NETWORK; NEUROIMAGING; PARKINSON DISEASE; PATH ANALYSIS; PATHOLOGICAL GAMBLING; PHOTON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PREFRONTAL CORTEX; PRIORITY JOURNAL; REST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRUCTURAL EQUATION MODELING;

AGED; ANALYSIS OF VARIANCE; BRAIN MAPPING; CORPUS STRIATUM; FEMALE; GAMBLING; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PREFRONTAL CORTEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79952645543     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23480     Document Type: Article

References (67)

1. Antonini A, Cilia R. Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention. Drug Saf 2009; 32: 475-488.
2. Voon V, Fernagut PO, Wickens J, et al. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. Lancet Neurol 2009; 8: 1140-1149.
3. Cools R, Barker RA, Sahakian BJ, Robbins TW. L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia 2003; 41: 1431-1441.
4. Frank MJ, Seeberger LC, O'reilly RC. By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 2004; 306: 1940-1943.
5. Bódi N, Kéri S, Nagy H, et al. Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients. Brain 2009; 132 (Part 9): 2385-2395.
6. Cilia R, Siri C, Marotta G, et al. Functional abnormalities underlying pathological gambling in Parkinson disease. Arch Neurol 2008; 65: 1604-1611.
7. Steeves TD, Miyasaki J, Zurowski M, et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 2009; 132 (Part 5): 1376-1385.
8. Lee DS, Kang H, Kim H, et al. Metabolic connectivity by interregional correlation analysis using statistical parametric mapping (SPM) and FDG brain PET; methodological development and patterns of metabolic connectivity in adults. Eur J Nucl Med Mol Imaging 2008; 35: 1681-1691.
9. McIntosh AR, Gonzalez-Lima F. Structural equation modeling and its application to network analysis in functional brain imaging. Hum Brain Mapp 1994; 2: 2-22.
10. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, DSM-IV-TR, Fourth ed. Washington, DC: American Psychiatric Association; 2000.
11. Lesieur HR, Blume SB. The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 1987; 144: 1184-1188.
12. Voon V, Thomsen T, Miyasaki JM, et al. Factors associated with dopaminergic medication-related pathological gambling in Parkinson disease. Arch Neurol 2007; 64: 212-216.
13. Holtgraves T. Evaluating the problem gambling severity index. J Gambl Stud 2009; 25: 105-120.
14. Deep-Brain Stimulation for Parkinson's Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001; 345: 956-963.
15. 99mTc-ECD). J Cereb Blood Flow Metab 1994; 14 (Suppl 1): S4-S11.
16. Friston KJ. Functional and effective connectivity in neuroimaging: a synthesis. Hum Brain Mapp 1994; 2: 56-78.
17. Hirao K, Ohnishi T, Matsuda H, et al. Functional interactions between entorhinal cortex and posterior cingulate cortex at the very early stage of Alzheimer's disease using brain perfusion single-photon emission computed tomography. Nucl Med Commun 2006; 27: 151-156.
18. Pagani M, Salmaso D, Rodriguez G, Nardo D, Nobili F. Principal component analysis in mild and moderate Alzheimer's disease-a novel approach to clinical diagnosis. Psychiatry Res 2009; 173: 8-14.
19. Hu L, Bentler P. Cutoff criteria for fit indices in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling 1999; 6: 1-55.
20. Jöreskog KG, Sörbom D. LISREL-VI user's guide, Third ed. Mooresville, IN: Scientific Software; 1984.
21. Akaike H. Factor analysis and AIC. Psychometrika 1987; 52: 317-332.
22. Byrne B. Structural equation modeling with AMOS: basic concepts, applications, and programming (multivariate applications series), Lawrence Erlbaum Associates, Inc., Publishers, 10 Industrial Avenue, Mahwah, New Jersey; Second ed. Kindle Edition; 2001.
23. Schumacker RE, Lomax RG. A Beginner's guide to structural equation modeling, second ed. Mahwah, NJ: Lawrence Erlbaum Associates, Inc.; 2004.
24. Seminowicz DA, Mayberg HS, McIntosh AR, et al. Limbic-frontal circuitry in major depression: a path modeling metanalysis. Neuroimage 2004; 22: 409-418.
25. Ottowitz WE, Derro D, Dougherty DD, Lindquist MA, Fischman AJ, Hall JE. FDG-PET analysis of amygdalar-cortical network covariance during pre- versus post-menopausal estrogen levels: potential relevance to resting state networks, mood, and cognition. Neuro Endocrinol Lett 2008; 29: 467-474.
26. Nyberg L, McIntosh AR, Cabeza R, et al. Network analysis of positron emission tomography regional cerebral blood flow data: ensemble inhibition during episodic memory retrieval. J Neurosci 1996; 16: 3753-3759.
27. Vorhold V. The neuronal substrate of risky choice: an insight into the contributions of neuroimaging to the understanding of theories on decision making under risk. Ann NY Acad Sci 2008; 1128: 41-52.
28. Schultz W. Getting formal with dopamine and reward. Neuron 2002; 36: 241-263.
29. Platt ML, Huettel SA. Risky business: the neuroeconomics of decision making under uncertainty. Nat Neurosci 2008; 11: 398-403.
30. Lerner A, Bagic A, Hanakawa T, et al. Involvement of insula and cingulate cortices in control and suppression of natural urges. Cereb Cortex 2009; 19: 218-223.
31. Robbins TW. Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications. Philos Trans R Soc Lond B Biol Sci 2007; 362: 917-932.
32. Horn NR, Dolan M, Elliott R, Deakin JF, Woodruff PW. Response inhibition and impulsivity: an fMRI study. Neuropsychologia 2003; 41: 1959-1966.
33. Aron AR, Fletcher PC, Bullmore ET, Sahakian BJ, Robbins TW. Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci 2003; 6: 115-116.
34. Aron AR, Robbins TW, Poldrack R. Inhibition and the right inferior frontal cortex. Trends Cogn Sci 2004; 8: 170-177.
35. Arnsten AF. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways. J Clin Psychiatry 2006; 67 (Suppl. 8): 7-12.
36. Garavan H, Hester R, Murphy K, Fassbender C, Kelly C. Individual differences in the functional anatomy of inhibitory control. Brain Res 2006; 1105: 130-142.
37. Windmann S, Kirsch P, Mier D, et al. On framing effects in decision making: linking lateral versus medial orbitofrontal cortex activation to choice outcome processing. J Cogn Neurosci 2006; 18: 1198-1211.
38. Picton TW, Stuss DT, Alexander MP, Shallice T, Binns MA, Gillingham S. Effects of focal frontal lesions on response inhibition. Cereb Cortex 2007; 17: 826-838.
39. Rogers RD, Owen AM, Middleton HC, et al. Choosing between small, likely rewards and large, unlikely rewards activates inferior and orbital prefrontal cortex. J Neurosci 1999; 19: 9029-9038.
40. Matthews SC, Simmons AN, Lane SD, Paulus MP. Selective activation of the nucleus accumbens during risk-taking decision making. Neuroreport 2004; 15: 2123-2127.
41. McClure SM, Laibson DI, Loewenstein G, Cohen JD. Separate neural systems value immediate and delayed monetary rewards. Science 2004; 306: 503-507.
42. Vorhold V, Giessing C, Wiedemann PM, Schütz H, Gauggel S, Fink GR. The neural basis of risk ratings: evidence from a functional magnetic resonance imaging (fMRI) study. Neuropsychologia 2007; 45: 3242-3250.
43. Floden D, Alexander MP, Kubu CS, Katz D, Stuss DT. Impulsivity and risk-taking behavior in focal frontal lobe lesions. Neuropsychologia 2008; 46: 213-223.
44. de Ruiter MB, Veltman DJ, Goudriaan AE, Oosterlaan J, Sjoerds Z, van den Brink W. Response perseveration and ventral prefrontal sensitivity to reward and punishment in male problem gamblers and smokers. Neuropsychopharmacology 2009; 34: 1027-1038.
45. Ridderinkhof KR, Ullsperger M, Crone EA, Nieuwenhuis S. The role of the medial frontal cortex in cognitive control. Science 2004; 306: 443-447.
46. Tanabe J, Thompson L, Claus E, et al. Prefrontal cortex activity is reduced in gambling and nongambling substance users during decision-making. Hum Brain Mapp 2007; 28: 1276-1286.
47. Matsumoto M, Matsumoto K, Abe H, Tanaka K. Medial prefrontal cell activity signaling prediction errors of action values. Nat Neurosci 2007; 10: 647-656.
48. Matthews SC, Simmons AN, Arce E, Paulus MP. Dissociation of inhibition from error processing using a parametric inhibitory task during functional magnetic resonance imaging. Neuroreport 2005; 16: 755-760.
49. Brown SM, Manuck SB, Flory JD, Hariri AR. Neural basis of individual differences in impulsivity: contributions of corticolimbic circuits for behavioral arousal and control. Emotion 2006; 6: 239-245.
50. Chevrier AD, Noseworthy MD, Schachar R. Dissociation of response inhibition and performance monitoring in the stop signal task using event-related fMRI. Hum Brain Mapp 2007; 28: 1347-1358.
51. Reuter J, Raedler T, Rose M, Hand I, Glascher J, Buchel C. Patholgical gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 2005; 8: 147-148.
52. Doya K. Modulators of decision making. Nat Neurosci 2008; 11: 410-416.
53. Rushworth MF, Behrens TE. Choice, uncertainty and value in prefrontal and cingulate cortex. Nat Neurosci 2008; 11: 389-397.
54. Parkinson JA, Willoughby PJ, Robbins TW, Everitt BJ. Disconnection of the anterior cingulate cortex and nucleus accumbens core impairs Pavlovian approach behavior: further evidence for limbic cortical ventral striatopallidal systems. Behav Neurosci 2000; 114: 42-63.
55. Block AE, Dhanji H, Thompson-Tardif SF, Floresco SB. Thalamic-prefrontal cortical-ventral striatal circuitry mediates dissociable components of strategy set shifting. Cereb Cortex 2007; 17: 1625-1636.
56. Potts GF, George MR, Martin LE, Barratt ES. Reduced punishment sensitivity in neural systems of behavior monitoring in impulsive individuals. Neurosci Lett 2006; 397: 130-134.
57. Leibenluft E, Rich BA, Vinton DT, et al. Neural circuitry engaged during unsuccessful motor inhibition in pediatric bipolar disorder. Am J Psychiatry 2007; 164: 52-60.
58. Mobbs D, Eckert MA, Mills D, et al. Frontostriatal dysfunction during response inhibition in Williams syndrome. Biol Psychiatry 2007; 62: 256-261.
59. Sinha R. Inhibitory control and emotional stress regulation: neuroimaging evidence for frontal-limbic dysfunction in psycho-stimulant addiction. Neurosci Biobehav Rev 2008; 32: 581-597.
60. Hayden BY, Platt ML. Gambling for Gatorade: risk-sensitive decision making for fluid rewards in humans. Anim Cogn 2009; 12: 201-207.
61. Jocham G, Klein TA, Neumann J, von Cramon DY, Reuter M, Ullsperger M. Dopamine DRD2 polymorphism alters reversal learning and associated neural activity. J Neurosci 2009; 29: 3695-3704.
62. Pochon JB, Levy R, Fossati P, et al. The neural system that bridges reward and cognition in humans: an fMRI study. Proc Natl Acad Sci USA 2002; 99: 5669-5674.
63. van Leijenhorst L, Crone EA, Bunge SA. Neural correlates of developmental differences in risk estimation and feedback processing. Neuropsychologia 2006; 44: 2158-2170.
64. Klein TA, Neumann J, Reuter M, Hennig J, von Cramon DY, Ullsperger M. Genetically determined differences in learning from errors. Science 2007; 318: 1642-1645.
65. Comings DE, Rosenthal RJ, Lesieur HR, et al. A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics 1996; 6: 223-234.
66. Gallagher DA, O'Sullivan SS, Evans AH, Lees AJ, Schrag A. Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord 2007; 22: 1757-1763.
67. Weintraub D. Impulse control disorders in Parkinson's disease: prevalence and possible risk factors. Parkinsonism Relat Disord 2009; 15 (Suppl 3): S110-S113.